PRL and neoplasm: Hence, we propose that chronic lack of physiological proapoptotic and antiproliferative actions of PRL, and/or changes in PRLR expression, could contribute to alterations in anterior pituitary cell renewal, leading to pituitary hyperplasia and, eventually, tumor development.